Michael P Curry
Affiliation: Harvard University
- HIV and hepatitis C virus: special concerns for patients with cirrhosisMichael P Curry
Liver Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
J Infect Dis 207:S40-4. 2013....
- Hepatitis B and hepatitis C viruses in liver transplantationMichael P Curry
Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Transplantation 78:955-63. 2004..This review summarizes available data and highlights appropriate strategies to improve outcomes...
- The gallbladder and biliary tract in cystic fibrosisMichael P Curry
Liver Transplantation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
Curr Gastroenterol Rep 7:147-53. 2005..Liver transplantation can be performed successfully in patients with end-stage liver disease. Future treatments involve targeted gene therapy and activation of mutant forms of the cystic fibrosis transmembrane conductance regulator...
- Use of growth factors with antiviral therapy for chronic hepatitis CMichael P Curry
Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
Clin Liver Dis 9:439-51, vii. 2005....
- Timing of sirolimus conversion influences recovery of renal function in liver transplant recipientsChristin C Rogers
Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, USA
Clin Transplant 23:887-96. 2009..The only improvement in the LC group was from conversion to the three-month time point. We conclude that EC to SRL results in a profound improvement in eGFR that begins at three months and is sustained beyond one yr...
- Liver transplant center risk toleranceScott R Johnson
The Transplant Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
Clin Transplant 26:E269-76. 2012..Small volume centers must perform higher risk transplants to meet current CMS requirements and are at risk for adverse action secondary to chance alone...
- Peripheral platelet count correlates with liver atrophy and predicts long-term mortality on the liver transplant waiting listWissam Bleibel
Liver Center, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA, USA
Transpl Int 26:435-42. 2013..01), but no different transplantation rate (36.7% vs. 33.3%, P = 0.64) compared to those with platelet count ≥ 100,000/mcL. Low platelet count corresponds to higher waiting list mortality and is a sign of advanced liver atrophy...
- A Simultaneous Liver-Kidney Transplant Recipient With IgA Nephropathy Limited to Native Kidneys and BK Virus Nephropathy Limited to the Transplant KidneyManasa P Ujire
The Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA
Am J Kidney Dis 62:331-4. 2013..These findings confirm the predilection of BK virus nephropathy for transplant rather than native kidneys. ..
- Patients' expectations and success criteria for liver transplantationJames R Rodrigue
Center for Transplant Outcomes and Quality Improvement, Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA
Liver Transpl 17:1309-17. 2011..Patient-centered assessments have the potential to facilitate provider-patient communication by helping patients to prioritize their goals for LT and make informed choices on the basis of those priorities...
- Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantationKaren J Ho
Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Transplantation 85:1588-94. 2008..We hypothesized that donor postextubation parameters, including duration and severity of hemodynamic instability or hypoxia might be a better predictor of subsequent graft function...
- Atypical radiological presentation of progressive multifocal leukoencephalopathy following liver transplantationMarco A Lima
Department of Neurology, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
J Neurovirol 11:46-50. 2005..The authors report an atypical presentation of PML with contrast-enhancing lesions and mass effect on the MRI in a liver transplant recipient,who had a progressive course and fatal outcome...
- Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liverMichael P Curry
The Liver Unit, St Vincent s University Hospital, Elm Park, Dublin 4, Ireland
J Hepatol 38:642-50. 2003....
- Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infectionTina Deignan
Education and Research Centre, St Vincent s University Hospital, Elm Park, Dublin 4, Ireland
J Hepatol 37:101-8. 2002..It is not known which of these populations contribute to immunity against HCV or immune pathology...